The test, along with other research-use tests for neurodegenerative disease, run on the Danaher subsidiary's DxI 9000 Immunoassay Analyzer system.
Aalo Atomics announced that its Critical Test Reactor at the Idaho National Laboratory successfully achieved initial criticality in the early hours of Saturday morning, becoming the fourth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results